Related Experiment Video

Updated: Jul 31, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
09:08

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer

Published on: January 12, 2020

Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human

D Wang1, T Kanuma, H Mizunuma

  • 1Department of Obstetrics and Gynecology, Gunma University School of Medicine, Japan.

Cancer Research
|September 2, 2000
PubMed

Insights

Mutations in the transforming growth factor beta (TGF-beta) receptor type I (RI) gene and its pathway are linked to ovarian cancer. This study identified specific mutations in TGF-beta RI and Smad2 genes in human ovarian tumors.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The transforming growth factor beta (TGF-beta) signaling pathway, involving receptors like TGF-beta RI and RII, and Smad proteins, acts as a tumor suppressor.
  • Mutations in key genes within this pathway (TGF-beta RI, RII, Smad2, Smad4) are implicated in various human cancers.

Purpose of the Study:

  • To investigate mutations in TGF-beta RI, TGF-beta RII, Smad2, and Smad4 genes in human ovarian cancers.
  • To analyze the correlation between these gene mutations and ovarian carcinogenesis.

Main Methods:

  • Analysis of gene mutations in 32 human ovarian cancers and 14 normal tissues using PCR-single-strand conformational polymorphism (PCR-SSCP).
  • Sequencing of identified variants to confirm mutations and polymorphisms.
  • Assessment of TGF-beta RI and p53 protein expression.

Main Results:

  • A frameshift mutation in TGF-beta RI exon 5 was found in 31.3% of tumors, associated with reduced protein expression.
  • Polymorphisms in TGF-beta RII intron 2 (A to G transition) were detected in 62.5% of tumors.
  • Smad2 variants in exon 4, linked to splice site alterations, were observed in 37.5% of tumors.
  • No Smad4 gene variants were detected.

Conclusions:

  • Mutations in the TGF-beta RI gene and its signal transduction pathway play a significant role in human ovarian carcinogenesis.
  • Specific mutations in TGF-beta RI and Smad2 may contribute to the development of ovarian cancer.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...